康臣葯業：2020中期報告.pdf

1、Kidney MedicinesHepatobiliary MedicinesOrthopedics MedicinesDermatologic MedicinesContrast MediumGastroenterology MedicinesWomen and Children Medicines腎科藥物肝膽藥物骨科藥物皮膚科藥物對比劑消化系統藥物婦兒藥物中期報告Interim Report2020 INTERIM REPORT 2020 中期報告1Corporate Information公司資料2-4Financial Highlights財務摘要5Management Discuss

2、ion and Analysis管理層討論及分析6-20Consolidated Statement of Profit or Loss綜合損益表21Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表22Consolidated Statement of Financial Position綜合財務狀況表23-24Consolidated Statement of Changes in Equity綜合權益變動表25-27Condensed Consolidated Cash F

3、low Statement簡明綜合現金流量表28Notes to the Unaudited Interim Financial Report未經審核中期財務報告附註29-53Review Report審閱報告54-55Other Information其他資料56-76Contents 目錄CONSUN PHARMACEUTICAL GROUP LIMITED 康臣葯業集團有限公司2公司資料Corporate InformationDIRECTORSExecutive DirectorsMr.AN Yubao(Chairman)Ms.LI Qian(Vice Chairlady,Chief

4、Executive Officer)Professor ZHU QuanMr.TANG Ning(resigned,effective from 29 May 2020)Independent Non-Executive DirectorsMr.SU YuanfuMr.FENG ZhongshiMs.CHEN YujunAUDIT COMMITTEEMs.CHEN Yujun(Chairlady)Mr.FENG ZhongshiMr.SU YuanfuNOMINATION COMMITTEEMr.SU Yuanfu(Chairman)Mr.AN YubaoMs.CHEN YujunREMUNE

5、RATION COMMITTEEMr.FENG Zhongshi(Chairman)Ms.LI QianMr.SU YuanfuCOMPANY SECRETARYMr.YAU Chi Ming(CPA)董事執行董事安郁寶先生（主席）黎倩女士（副主席、總裁）朱荃教授唐寧先生（已辭任，自2020年5月29日起生效）獨立非執行董事蘇元福先生馮仲實先生陳玉君女士審核委員會陳玉君女士（主席）馮仲實先生蘇元福先生提名委員會蘇元福先生（主席）安郁寶先生陳玉君女士薪酬委員會馮仲實先生（主席）黎倩女士蘇元福先生公司秘書丘志明先生（執業會計師）INTERIM REPORT 2020 中期報告3公司資料Corpor

6、ate InformationAUTHORISED REPRESENTATIVES FORTHE PURPOSE OF THE LISTING RULESMr.AN YubaoMr.YAU Chi MingAUDITORKPMGPublic Interest Entity Auditor registered in accordancewith the Financial Reporting Council Ordinance8th Floor,Princes Building10 Chater Road,Central,Hong KongLEGAL ADVISER(AS TO HONG KO